Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.390
-0.060 (-4.14%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $67.08 million as of February 21, 2025. Its market cap has decreased by -2.80% in one year.
Market Cap
67.08M
Enterprise Value
-62.56M
1-Year Change
-2.80%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $67.08M, a decrease of -87.88%. That is a compound annual growth rate of -41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 67.08M | -15.24% |
| Dec 31, 2024 | 79.14M | -16.75% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |